|
CA3086653A1
|
|
Tumor necrosis factor (tnf) receptor superfamily (tnfrsf) receptor-activating antibody fusion proteins with fcyr-independent agonistic activity (tnfrsf receptor-activating antibody fusion proteins with fcyr-independ ent agonistic activity; traaffiaa)
|
|
CA3082334A1
|
|
Cd19cart cells eliminate myeloma cells that express very low levels of cd19
|
|
CN110945019A
|
|
Combination of MHC class Ib molecules and peptides for targeted therapy for immunomodulation
|
|
CA3018435A1
|
|
Glycosylated mono(2-hydroxyethyl) terephthalic acid and glycosylated bis(2-hydroxyethyl) terephthalic acid
|
|
CA3000293A1
|
|
Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
|
|
AU2013205476A1
|
|
Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
|
|
AU2013208895A1
|
|
Dual antigen-induced bipartite functional complementation
|
|
AU2008348842A1
|
|
Method and device for determining a pressure parameter of a plant sample
|
